ArticleAnnals of the rheumatic diseases2022

Response to: 'Riociguat in systemic sclerosis: a potential for disease modification' by Jain and Dhir.

Dinesh Khanna et al.PubMed ↗Publisher ↗

No numbers read from the abstract.